![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
X
1. 95462-15-0
2. (+)-lycopsamine N-oxide
3. [(7r,8r)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3h-pyrrolizin-4-ium-1-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
4. Lycopsamine N-oxide , Hplc Grade
5. Hy-n9512
6. Mfcd31697780
7. Nsc369514
8. Nsc-369514
9. Cs-0182699
Molecular Weight | 315.36 g/mol |
---|---|
Molecular Formula | C15H25NO6 |
XLogP3 | -1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 315.16818752 g/mol |
Monoisotopic Mass | 315.16818752 g/mol |
Topological Polar Surface Area | 105 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 479 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |